# Title
Identification O
of O
the O
human B-Species
cytochromes O
P450 O
catalysing O
the O
rate-limiting O
pathways O
of O
gliclazide B-Chemical
elimination. O

# Abstract
AIMS: O
To O
identify O
the O
human B-Species
cytochrome O
P450 O
(CYP) O
enzymes O
responsible O
for O
the O
formation O
of O
the O
6beta-hydroxy B-Chemical
(6beta-OHGz), B-Chemical
7beta-hydroxy B-Chemical
(7beta-OHGz) B-Chemical
and O
hydroxymethyl B-Chemical
(MeOH-Gz) B-Chemical
metabolites O
of O
gliclizide B-Chemical
(Gz). B-Chemical
METHODS: O
6beta-OHGz, B-Chemical
7beta-OHGz B-Chemical
and O
MeOH-Gz B-Chemical
formation O
by O
human B-Species
liver O
microsomes O
and O
a O
panel O
of O
recombinant O
human B-Species
P450s O
was O
measured O
using O
a O
high-performance O
liquid O
chromatography O
procedure, O
and O
the O
kinetics O
of O
metabolite O
formation O
was O
determined O
for O
each O
pathway. O
Effects O
of O
prototypic O
CYP O
enzyme O
selective O
inhibitors O
were O
characterized O
for O
each O
of O
the O
microsomal O
metabolic O
pathways. O
RESULTS: O
Microsomes O
from O
six O
human B-Species
livers O
converted O
Gz B-Chemical
to O
its O
6beta-OHGz, B-Chemical
7beta-OHGz, B-Chemical
and O
MeOH-Gz B-Chemical
metabolites, O
with O
respective O
mean O
(+ O
- O
SD) O
K(m) O
values O
of O
461 O
+ O
- O
139, O
404 O
+ O
- O
143 O
and O
334 O
+ O
- O
75 O
microm O
and O
mean O
V(max) O
values O
of O
130 O
+ O
- O
55, O
82 O
+ O
- O
31 O
and O
268 O
+ O
- O
115 O
pmol O
min(-1) O
mg(-1), O
respectively. O
V(max) O
K(m) O
ratios O
for O
the O
microsomal O
reactions O
parallelled O
relative O
metabolite O
formation O
in O
vivo. O
Sulfaphenazole B-Chemical
inhibited O
microsomal O
6beta-OHGz, B-Chemical
7beta-OHGz B-Chemical
and O
MeOH-Gz B-Chemical
formation O
by O
87, O
83 O
and O
64%, O
respectively, O
whereas O
S-mephenytoin B-Chemical
caused O
significant O
inhibition O
(48%) O
of O
only O
MeOH-Gz B-Chemical
formation. O
Recombinant O
CYP2C9, B-Gene
CYP2C18 B-Gene
and O
CYP2C19 B-Gene
catalysed O
all O
hydroxylation O
pathways, O
whereas O
CYP2C8 B-Gene
formed O
only O
6beta-OHGz B-Chemical
and O
7beta-OHGz. B-Chemical
CONCLUSION: O
Taken O
together, O
the O
results O
indicate O
that O
CYP2C9 B-Gene
is O
the O
major O
contributor O
to O
Gz B-Chemical
metabolic O
clearance, O
although O
CYP2C19 B-Gene
may O
also O
be O
involved O
in O
MeOH-Gz B-Chemical
formation O
(the O
major O
metabolic O
pathway). O
Factors O
known O
to O
influence O
CYP2C9 B-Gene
activity O
will O
provide O
the O
main O
source O
of O
variability O
in O
Gz B-Chemical
pharmacokinetics. O